ATE316098T1 - Malaria polypeptide - Google Patents

Malaria polypeptide

Info

Publication number
ATE316098T1
ATE316098T1 AT98945703T AT98945703T ATE316098T1 AT E316098 T1 ATE316098 T1 AT E316098T1 AT 98945703 T AT98945703 T AT 98945703T AT 98945703 T AT98945703 T AT 98945703T AT E316098 T1 ATE316098 T1 AT E316098T1
Authority
AT
Austria
Prior art keywords
malaria
receptors
acting
relates
ligands
Prior art date
Application number
AT98945703T
Other languages
English (en)
Inventor
Mats Wahlgren
Antonio Barragan
Johan Carlson
Chen Qijun
Victor Fernandez
Original Assignee
Mats Wahlgren
Chen Qijun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mats Wahlgren, Chen Qijun filed Critical Mats Wahlgren
Application granted granted Critical
Publication of ATE316098T1 publication Critical patent/ATE316098T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98945703T 1997-09-19 1998-09-18 Malaria polypeptide ATE316098T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703386A SE9703386D0 (sv) 1997-09-19 1997-09-19 Malaria polypeptides

Publications (1)

Publication Number Publication Date
ATE316098T1 true ATE316098T1 (de) 2006-02-15

Family

ID=20408305

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98945703T ATE316098T1 (de) 1997-09-19 1998-09-18 Malaria polypeptide

Country Status (8)

Country Link
US (1) US7125958B1 (de)
EP (1) EP1015483B1 (de)
AT (1) ATE316098T1 (de)
AU (1) AU747741B2 (de)
DE (1) DE69833265T2 (de)
ES (1) ES2257818T3 (de)
SE (1) SE9703386D0 (de)
WO (1) WO1999015557A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190183997A1 (en) * 2016-07-22 2019-06-20 University Of Washington Identification and production of high affinity igm antibodies and derivatives thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003181D0 (sv) * 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction
US5993827A (en) * 1993-09-10 1999-11-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
JPH09502353A (ja) * 1993-09-10 1997-03-11 アメリカ合衆国 プラスモジウム・ビバックスおよびプラスモジウム・ファルシパルム赤血球結合蛋白質からの結合領域
US5911991A (en) * 1993-10-21 1999-06-15 New York Blood Center, Inc. Malarial binding site in duffy blood group protein
FR2732219B1 (fr) * 1995-03-27 1997-05-30 Pasteur Institut Compositions pharmaceutiques pour la prevention et le traitement du paludisme, a base d'un membre de la famille des chondroitine-glycosaminoglycanes
AU5851296A (en) * 1995-04-27 1996-11-18 Affymax Technologies N.V. Malaria peptides and vaccines
US6120770A (en) * 1997-09-12 2000-09-19 University Of Notre Dame Du Lac Plasmodium proteins useful for preparing vaccine compositions
US6673601B1 (en) * 1999-04-15 2004-01-06 Institut Pasteur Chimeric lyssavirus nucleic acids and polypeptides
WO2001016326A2 (en) * 1999-09-01 2001-03-08 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a
GB0019375D0 (en) * 2000-08-07 2000-09-27 Int Centre Genetic Eng & Bio Method of polypeptide renaturation
WO2002078603A2 (en) * 2001-04-02 2002-10-10 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine
US20060088501A1 (en) * 2004-10-21 2006-04-27 New York Blood Center, Inc. Duffy antigen receptor for chemokines and use thereof

Also Published As

Publication number Publication date
AU747741B2 (en) 2002-05-23
ES2257818T3 (es) 2006-08-01
EP1015483A1 (de) 2000-07-05
SE9703386D0 (sv) 1997-09-19
US7125958B1 (en) 2006-10-24
EP1015483B1 (de) 2006-01-18
DE69833265T2 (de) 2006-09-28
WO1999015557A1 (en) 1999-04-01
DE69833265D1 (de) 2006-04-06
AU9288498A (en) 1999-04-12

Similar Documents

Publication Publication Date Title
IT8367525A0 (it) Proteina ibrida comprendente frammenti proteici collegati da legami peptidici e relativo gene di fusione composizione contenente tale proteina
TR199801041T2 (xx) Kanabinoid resept�r afinitesine sahip olan 3-pirazolkarboksamid t�revleri.
PT994903E (pt) Metodos e composicoes para glicoproteinas galactosiladas
DK0554344T3 (da) Farmaceutisk præparat til behandling eller forebyggelse af en malign tumor
EP0871702A4 (de) Cytokin lerk-7
TR200000654T2 (tr) KAY-Yeni bir bağışıklık sistemi proteini.
CY1117551T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
EP2272859A3 (de) Immunologische Herpes-Simplex Antigene und Verfahren zu ihrer Verwendung
FI972945A7 (fi) Antigeenien antamiseen soveltuvia koostumuksia
EP0746398A4 (de) Antikörperreinigung
UA27763C2 (uk) Рекомбінантна молекула днк, що кодує молекулу адгезії icam-3, молекула адгезії icam-3, антитіло, здатне зв'язуватись з такою молекулою, фармацевтична композиція
NO910922L (no) Tris-maleimidoforbindelser som mellomprodukter i trifunksjonell antistoffsyntese.
PT888384E (pt) Polipeptido de fusao para influenciar as interaccoes entre proteinas
DE69824719D1 (de) Cytokinähnlicher faktor-7 aus säugetieren
EA199800230A1 (ru) Тетрагидрохинолины в качестве антагонистов nmda (n-метил-d-аспарагиновой кислоты)
ATE237343T1 (de) Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik
ATE316098T1 (de) Malaria polypeptide
ATE207935T1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
FI943218L (fi) Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt
EA199700223A1 (ru) Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
DE3485219D1 (de) Tgf-polypeptide, davon derivierte antigene oligopeptide, davon erhaltene antikoerper.
EP1103561A4 (de) Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt
IT1284870B1 (it) Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi
EA199801032A1 (ru) Белки zona pellucida для контрацепции
TR199902605T2 (xx) Fibrinojenin azalt�lma y�ntemleri.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1015483

Country of ref document: EP

REN Ceased due to non-payment of the annual fee